Differential effects of novel kappa opioid receptor antagonists on dopamine neurons using acute brain slice electrophysiology | PLOS ONE
A unique natural selective kappa-opioid receptor agonist, salvinorin A, and its roles in human therapeutics - ScienceDirect
Signaling Properties of Structurally Diverse Kappa Opioid Receptor Ligands: Toward in Vitro Models of in Vivo Responses | ACS Chemical Neuroscience
Opioid Receptors - Pharmacology
Opioid receptors: drivers to addiction? | Nature Reviews Neuroscience
Advances in Sulfonamide Kappa Opioid Receptor Antagonists: Structural Refinement and Evaluation of CNS Clearance | ACS Chemical Neuroscience
Opioid Receptor | kappa, mu Opioid Receptor
Biased agonists of the kappa opioid receptor suppress pain and itch without causing sedation or dysphoria | Science Signaling
Opioid receptors - @ a glance
Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists
Opioid receptors | Introduction | BPS/IUPHAR Guide to PHARMACOLOGY
Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists
Opioids in cancer: The κ‑opioid receptor (Review)
Kappa-opioid receptor-dependent changes in dopamine and anxiety-like or approach-avoidance behavior occur differentially across the nucleus accumbens shell rostro-caudal axis - ScienceDirect